Skip Ribbon Commands
Skip to main content
Investors
Webcasts and Presentations
Click here for webcast
Q2 2016 West Pharmaceutical Services Earnings Conference Call
July 28, 2016 9:00 a.m. ET
NYSE: WSTSee Quotes >>
LAST: 78.06 4:02 p.m. ET
Change: 0.00    .00%
See Chart >>

Shareholders may receive, free of charge, a hard copy of West Pharmaceutical Service's complete audited financial statements by sending a written request to West Pharmaceutical Services, Inc. Attn: Company's Secretary, 530 Herman O. West Drive, Exton, PA 19341.

Latest Releases
7/14/2016 8:30:51 AM
West to Host Second Quarter 2016 Conference Call
7/11/2016 9:11:53 AM
West's SmartDose® Drug Delivery Technology Platform Selected by Amgen for Pushtronex™ System
7/5/2016 4:30:55 PM
West Announces Quarterly Dividend
Corporate Overview

West Pharmaceutical Services, Inc. is a global pharmaceutical technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines and consumer healthcare products.

West is the world's premiere provider of standard-setting systems and device components for parenterally administered medicines.

Internationally headquartered in Exton, Pa., West supports its partners and customers from 50 locations throughout North America, South America, Europe, and the Asia Pacific region.

Investor Contacts

Quintin Lai Ph.D.
Vice President, Corporate Development, Strategy and Investor Relations
610-594-3318
Quintin.Lai@westpharma.com